Opportunity Information: Apply for CDC RFA GH15 15810201SUPP16
Apply for CDC RFA GH15 15810201SUPP16
- The Department of Health and Human Services, Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Program Expansion Supplement: Strengthening HIV/TB Laboratory Quality Management Systems and Services in the Kingdom of Swaziland under the President's Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
- This funding opportunity was created on Aug 02, 2016.
- Applicants must submit their applications by Oct 01, 2016 Electronically submitted applications must be submitted no later than 1159 p.m., ET, on the listed application due date.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $1,628,300.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This funding opportunity is a PEPFAR-supported cooperative agreement from the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC), focused on expanding and strengthening HIV and TB laboratory services across the Kingdom of Swaziland (now Eswatini). The central problem it targets is that people living with HIV and/or TB are not consistently able to get reliable, quality-assured diagnostic and treatment-monitoring test results, largely because the national laboratory system is under-resourced and heavily dependent on expatriate staff. The opportunity frames laboratory quality and access as foundational to effective HIV and TB care, since treatment decisions and long-term patient management depend on accurate, timely testing.
A major driver behind the supplement is the shift in HIV care standards from CD4 testing to viral load monitoring. Viral load testing is now the key tool for monitoring whether antiretroviral therapy is working, identifying treatment failure early, and supporting the country s Test and Start approach, where clients begin treatment immediately after diagnosis. The announcement emphasizes that Swaziland s existing laboratory infrastructure cannot yet support the scale-up required for routine viral load analysis and reporting. Specific constraints highlighted include insufficient capacity to purchase and operate the necessary viral load equipment, limited staffing to run expanded testing services, and inadequate specimen transport and laboratory information systems needed to move samples and results efficiently between facilities and testing sites.
The stated purpose of the FOA is to work directly with the Swaziland Health Laboratory Service to implement its strategic plan and build a stronger nationwide laboratory system. The activities are centered on improving laboratory quality management systems, expanding and decentralizing access to services so that clients across the country can obtain needed tests, and developing a sustainable workforce of laboratory professionals who can support viral load testing and broader HIV/TB laboratory needs. The workforce issue is presented as urgent: roughly 72 percent of lab workers are expatriates, and many salaries are donor-supported, which creates long-term sustainability risks and contributes to instability in service delivery when external support changes.
The scope is national and system-wide rather than limited to a handful of sites. It covers every public, mission, and industry-managed health facility in Swaziland, signaling an intent to strengthen the entire laboratory network, not only central reference laboratories. In practical terms, that implies coordinated improvements that connect facility-level sample collection, transport to testing hubs, standardized testing procedures, quality assurance and quality control practices, data and result reporting systems, and the training and mentoring structures needed to keep performance consistent over time.
Administratively, this is listed as a discretionary award using a cooperative agreement mechanism, meaning CDC expects substantial involvement in guiding or collaborating on implementation rather than simply issuing funds with minimal federal engagement. The opportunity number is CDC RFA GH15-15810201SUPP16 under CFDA 93.067. The award ceiling is $1,628,300, with an expectation of one award, indicating a single implementing partner would likely coordinate the expansion supplement activities nationally. The posting shows a creation date of August 2, 2016, and an original closing date of October 1, 2016, with electronic submissions due by 11:59 p.m. ET on the deadline.
Overall, the opportunity is designed to close the gap between national HIV/TB clinical guidelines and the real-world capacity of the laboratory system by improving quality management, expanding viral load monitoring capability, strengthening sample transport and information systems, and reducing dependence on expatriate staffing through development of locally based laboratory professionals.
Frequently Asked Questions (FAQs)
What is this funding opportunity?
This opportunity is a PEPFAR-supported cooperative agreement from the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC). It focuses on expanding and strengthening HIV and TB laboratory services across the Kingdom of Swaziland (now Eswatini).
What problem is the grant trying to solve?
It targets gaps in reliable, quality-assured diagnostic and treatment-monitoring test results for people living with HIV and/or TB. The opportunity highlights that the national laboratory system is under-resourced and heavily dependent on expatriate staff, which contributes to inconsistent access and quality.
Why are laboratory services described as foundational to HIV and TB care?
The announcement frames lab quality and access as essential because treatment decisions and long-term patient management depend on accurate and timely testing. Without dependable results, clinicians cannot consistently monitor treatment effectiveness or manage patients over time.
What change in HIV care standards is driving this supplement?
A major driver is the shift from CD4 testing to viral load monitoring as the primary approach for monitoring antiretroviral therapy. Viral load testing is emphasized as the key tool for checking whether treatment is working and identifying treatment failure early.
How does viral load testing support the country's "Test and Start" approach?
The opportunity explains that viral load testing is central to Test and Start, where clients begin treatment immediately after diagnosis, because viral load monitoring helps track treatment success and supports ongoing clinical management after rapid initiation.
What limitations in the current laboratory system are highlighted?
The FOA points to several constraints: insufficient capacity to purchase and operate viral load equipment, limited staffing to run expanded testing services, and inadequate specimen transport and laboratory information systems needed to move samples and results efficiently between facilities and testing sites.
What is the purpose of the FOA?
The stated purpose is to work directly with the Swaziland Health Laboratory Service to implement its strategic plan and build a stronger nationwide laboratory system. The work is aimed at improving laboratory quality management, expanding and decentralizing access to services, and developing a sustainable laboratory workforce.
What types of activities does the opportunity emphasize?
Activities are centered on strengthening laboratory quality management systems, scaling up viral load monitoring capability, improving specimen transport and laboratory information systems, and building training and mentoring structures to sustain performance. The FOA also emphasizes reducing dependence on expatriate staffing through development of locally based laboratory professionals.
How significant is the expatriate staffing issue according to the announcement?
The opportunity describes the workforce issue as urgent, noting that roughly 72 percent of laboratory workers are expatriates. It also notes that many salaries are donor-supported, creating long-term sustainability risks and potential instability if external support changes.
What is the geographic and program scope of the work?
The scope is national and system-wide across Swaziland (Eswatini), rather than limited to a few sites. It covers every public, mission, and industry-managed health facility, indicating the intent is to strengthen the entire laboratory network.
Does the opportunity focus only on central reference laboratories?
No. The FOA signals a network approach that connects facility-level sample collection, transport to testing hubs, standardized procedures, quality assurance and quality control practices, data and result reporting systems, and ongoing workforce development.
What award mechanism is being used?
It is a discretionary award using a cooperative agreement mechanism. This means CDC expects substantial involvement in guiding or collaborating on implementation, rather than providing funding with minimal federal engagement.
Who is the federal funding agency?
The funding agency is the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC).
What is the opportunity number and CFDA number?
The opportunity number is CDC RFA GH15-15810201SUPP16, under CFDA 93.067.
What is the maximum award amount (ceiling)?
The award ceiling listed is $1,628,300.
How many awards are expected?
The posting indicates an expectation of one award, suggesting a single implementing partner would likely coordinate the expansion supplement activities nationally.
When was the opportunity posted, and what was the closing deadline?
The posting shows a creation date of August 2, 2016, and an original closing date of October 1, 2016.
When were electronic submissions due?
Electronic submissions were due by 11:59 p.m. ET on the deadline date listed (October 1, 2016).
What overall outcome is the opportunity trying to achieve?
Overall, the opportunity is designed to close the gap between national HIV/TB clinical guidelines and real-world laboratory capacity by improving quality management, expanding viral load monitoring capability, strengthening specimen transport and information systems, and reducing reliance on expatriate staffing through development of local laboratory professionals.
Browse more opportunities from the same category: Health
Next opportunity: Program Expansion Supplement: Improving Quality of Care and Health Impact through Sustainable, Integrated, Innovative Information System Technologies in Malawi under the President's Emergency Plan for AIDS Relief (PEPFAR)
Previous opportunity: UWNPS Research Center Support
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH15 15810201SUPP16
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH15 15810201SUPP16) also looked into and applied for these:
| Funding Opportunity |
|---|
| Program Expansion Supplement: Improving Quality of Care and Health Impact through Sustainable, Integrated, Innovative Information System Technologies in Malawi under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH12 12500401SUPP16 Funding Number: CDC RFA GH12 12500401SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $500,000 |
| Program Expansion Supplement for Planning, Implementation and Evaluation of Comprehensive HIV Prevention Programs in South Africa under PEPFAR Apply for CDC RFA GH11 11520502SUPP16 Funding Number: CDC RFA GH11 11520502SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $876,491 |
| Program Expansion Supplement: Strengthening High Quality Laboratory Services Scale-up for HIV Diagnosis, Care, Treatment and Monitoring in Malawi under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 15510201SUPP16 Funding Number: CDC RFA GH15 15510201SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $1,345,600 |
| Program Expansion Supplement: Strengthening Local Capacity to Provide Sustainable HIV-Related Care and Treatment Services in South Africa Apply for CDC RFA GH11 11090501SUPP16 Funding Number: CDC RFA GH11 11090501SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $15,000,000 |
| Program Expansion Supplement: Technical Assistance Services to Countries Supported by the President's Emergency Plan for HIV/AIDS Relief (PEPFAR) and the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria Apply for CDC RFA GH13 13680302SUPP16 Funding Number: CDC RFA GH13 13680302SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $900,000 |
| National Hemophilia Program Coordinating Center Apply for HRSA 17 087 Funding Number: HRSA 17 087 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Improvement of Laboratory and Clinical Services, and Collaboration across the National HIV and TB Programs in Vietnam under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH17 1711 Funding Number: CDC RFA GH17 1711 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $500,000 |
| Regional Hemophilia Network Apply for HRSA 17 074 Funding Number: HRSA 17 074 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Polio Eradication and Emergency Response in Priority Countries Apply for CDC RFA GH16 172102CONT17 Funding Number: CDC RFA GH16 172102CONT17 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Program Expansion Supplement: Strengthening Local Capacity to Deliver Sustainable Quality-Assured Universal Coverage of Clinical HIV/TB Services and Provide Central Level Technical Assistance in Swaziland Natl AIDS Program under PEPFAR Apply for CDC RFA GH15 15820201SUPP16 Funding Number: CDC RFA GH15 15820201SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $355,549 |
| Cooperative Agreement on Immunization with United Nations Children's Fund (UNICEF) Apply for CDC RFA GH13 13020401SUPP16 Funding Number: CDC RFA GH13 13020401SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Program Expansion Supplement: Support for Strengthening and Expanding HIV/AIDS Surveillance Activities in SA under PEPFAR Apply for CDC RFA GH11 11540501SUPP16 Funding Number: CDC RFA GH11 11540501SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $3,500,000 |
| Delivering Comprehensive Services to Achieve HIV Epidemic Control in Subnational Units in Nigeria under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH17 1753 Funding Number: CDC RFA GH17 1753 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $200,000,000 |
| Building the Capacity of the Government of Suriname to Address Gaps in the HIV Continuum of Care for Key Populations and People Living with HIV (PLHIV) under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH17 1774 Funding Number: CDC RFA GH17 1774 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $300,000 |
| Program Expansion Supplement for Planning, Implementation and Evaluation of Comprehensive HIV Prevention Programs in South Africa under PEPFAR Apply for CDC RFA GH11 11520501SUPP16 Funding Number: CDC RFA GH11 11520501SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $3,604,705 |
| Supporting Local Indigenous Faith-Based Partners in Providing High Quality HIV Care, Prevention and Treatment Services and Improving Linkage and Retention in the Republic of Guyana under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH17 1721 Funding Number: CDC RFA GH17 1721 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $465,000 |
| Support for Quality Facility and Community-based Antiretroviral Therapy (ART) for Adults and Children in Cameroon under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH17 1718 Funding Number: CDC RFA GH17 1718 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $10,000,000 |
| Strengthening Care and Support Services for Highly Vulnerable Populations, Orphans and Vulnerable Children and their Families, plus HIV Prevention for Youth in the Republic of Cote d'Ivoire under PEPFAR Apply for CDC RFA GH17 1755 Funding Number: CDC RFA GH17 1755 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $18,000,000 |
| Projecto de Saúde Para Todos (Health for All, or HFA) Apply for NFO RFA 654 16 000004 Funding Number: NFO RFA 654 16 000004 Agency: Agency for International Development, South Africa USAID-Pretoria Category: Health Funding Amount: $63,000,000 |
| Program Expansion Supplement: Scaling up Voluntary Medical Male Circumcision through improvement in HIV prevention under PEPFAR Apply for CDC RFA GH13 13280401SUPP16 Funding Number: CDC RFA GH13 13280401SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $3,000,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH15 15810201SUPP16", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.